Skip to main content

Forearm Fracture

2
Pipeline Programs
4
Companies
4
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
1
1
Early DiscoveryClinical DevelopmentMarket

Drug Modality Breakdown

Small Molecule
1100%
+ 3 programs with unclassified modality

Competitive Landscape

4 companies ranked by most advanced pipeline stage

Sandoz
SandozAustria - Kundl
1 program
1
Salmon calcitoninPhase 4
Marius Pharmaceuticals
1 program
1
IbuprofenPhase 3Small Molecule1 trial
Active Trials
NCT01567072Completed192Est. Sep 2016
Bioretec
BioretecFinland - Tampere
1 program
PLGA implant, Bioretec ltd. FinlandN/A1 trial
Active Trials
NCT03474900Completed35Est. Dec 2018
Novartis
NovartisBASEL, Switzerland
1 program
Salmon calcitoninPHASE_42 trials
Active Trials
NCT00395395Completed56
NCT00239889Completed300

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
NovartisSalmon calcitonin
Marius PharmaceuticalsIbuprofen
NovartisSalmon calcitonin
BioretecPLGA implant, Bioretec ltd. Finland

Clinical Trials (4)

Total enrollment: 583 patients across 4 trials

NCT00239889NovartisSalmon calcitonin

Efficacy and Safety of Salmon Calcitonin Nasal Spray in Improving Muscle Strength and Reducing Pain After Forearm Fracture in Postmenopausal Women

Start: Mar 2002300 patients
Phase 4Completed
NCT01567072Marius PharmaceuticalsIbuprofen

Non Steroidal Antiinflammatory Drugs Influence on Heal of Distal Radius Fracture

Start: Apr 2012Est. completion: Sep 2016192 patients
Phase 3Completed
NCT00395395NovartisSalmon calcitonin

Effects of Water and Food Intake on the Pharmacokinetics and Pharmacodynamics of Oral Salmon Calcitonin in Healthy Postmenopausal Women

Start: Oct 200656 patients
Phase 1Completed
NCT03474900BioretecPLGA implant, Bioretec ltd. Finland

Biodegradable Versus Titanium Nailing in Forearm Shaft Fractures in Children

Start: Feb 2011Est. completion: Dec 201835 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 late-stage (Phase 3) programs, potential near-term approvals
4 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.